FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213092103> ?p ?o ?g. }

• W4213092103 abstract "Fecal microbiota transplantation (FMT) has been widely performed for ulcerative colitis (UC) treatment at the clinical trial stage. Previous reports have used multiple FMT methods to enhance the colonization of healthy donor microbiota in the recipient's intestines. FMT following triple antibiotic therapy with amoxicillin, fosfomycin, and metronidazole (A-FMT) is not only effective but also requires only one FMT, which improves dysbiosis caused by reduced Bacteroidetes diversity in patients with UC. Alginate and its derivatives have the potential to induce the growth of intestinal bacteria including Bacteroides members and produce short-chain fatty acids (SCFAs), which are beneficial in regulating overactive autoimmunity. Our trial aims to investigate whether post-intervention with alginate, which can improve the intestinal environment, will enhance the therapeutic effect of A-FMT in UC and increase the long-term remission rate.This trial is a double-blinded, randomized, placebo-controlled, parallel assignment trial. Patients with UC and fecal donation candidates will undergo strict screening before being involved in the trial. Eligible patients are randomly divided into two groups: one group will drink one bottle of alginate twice a day for 8 consecutive weeks after A-FMT, while the other group will take a placebo instead of the alginate drink. The primary endpoints are the changes in the Total Mayo Score at 8 weeks after study initiation and A-FMT from baseline. The secondary endpoint is the comparison of clinical features, microbiota, and metabolomic analysis before and after 8 weeks of study food intake. Changes at 6, 12, 18, and 24 months after A-FMT will be assessed. Finally, a subpopulation analysis of the relationship between patients and donors is an exploratory endpoint.The FMT post-treatment used in this study is an oral alginate drink that is easily accepted by patients. If the regimen achieves the desired results, it can further improve the A-FMT regimen and provide evidence for clinical practice guidelines for UC.https://jrct.niph.go.jp/latest-detail/jRCTs031200103, identifier: jRCTs031200103." @default.
• W4213092103 created "2022-02-24" @default.
• W4213092103 creator A5003681835 @default.
• W4213092103 creator A5009586319 @default.
• W4213092103 creator A5012493910 @default.
• W4213092103 creator A5017132051 @default.
• W4213092103 creator A5034500754 @default.
• W4213092103 creator A5057705404 @default.
• W4213092103 creator A5080149508 @default.
• W4213092103 creator A5080621630 @default.
• W4213092103 creator A5088406552 @default.
• W4213092103 date "2022-02-22" @default.
• W4213092103 modified "2023-10-18" @default.
• W4213092103 title "A Randomized Placebo-Controlled Trial of Combination Therapy With Post-triple-antibiotic-therapy Fecal Microbiota Transplantation and Alginate for Ulcerative Colitis: Protocol" @default.
• W4213092103 cites W1533313469 @default.
• W4213092103 cites W1535399284 @default.
• W4213092103 cites W1981266729 @default.
• W4213092103 cites W1988997667 @default.
• W4213092103 cites W1993316662 @default.
• W4213092103 cites W1994882377 @default.
• W4213092103 cites W2003342633 @default.
• W4213092103 cites W2011168613 @default.
• W4213092103 cites W2014929619 @default.
• W4213092103 cites W2045226654 @default.
• W4213092103 cites W2045647658 @default.
• W4213092103 cites W2056978288 @default.
• W4213092103 cites W2060185417 @default.
• W4213092103 cites W2076829601 @default.
• W4213092103 cites W2078754045 @default.
• W4213092103 cites W2085448435 @default.
• W4213092103 cites W2089845295 @default.
• W4213092103 cites W2135717147 @default.
• W4213092103 cites W2152751713 @default.
• W4213092103 cites W2164027931 @default.
• W4213092103 cites W2189533272 @default.
• W4213092103 cites W2274065656 @default.
• W4213092103 cites W2319425357 @default.
• W4213092103 cites W2408960444 @default.
• W4213092103 cites W2524172848 @default.
• W4213092103 cites W2547000020 @default.
• W4213092103 cites W2554466792 @default.
• W4213092103 cites W2571820890 @default.
• W4213092103 cites W2588070196 @default.
• W4213092103 cites W2732891761 @default.
• W4213092103 cites W2755498570 @default.
• W4213092103 cites W2791326569 @default.
• W4213092103 cites W2885920472 @default.
• W4213092103 cites W2889311756 @default.
• W4213092103 cites W2903406988 @default.
• W4213092103 cites W2910898181 @default.
• W4213092103 cites W2936474142 @default.
• W4213092103 cites W2948865301 @default.
• W4213092103 cites W3001047124 @default.
• W4213092103 cites W3007781032 @default.
• W4213092103 cites W3029841383 @default.
• W4213092103 cites W3036511994 @default.
• W4213092103 cites W3135483428 @default.
• W4213092103 cites W3153696845 @default.
• W4213092103 cites W3182088130 @default.
• W4213092103 cites W4211050664 @default.
• W4213092103 cites W4251404301 @default.
• W4213092103 doi "https://doi.org/10.3389/fmed.2022.779205" @default.
• W4213092103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35273972" @default.
• W4213092103 hasPublicationYear "2022" @default.
• W4213092103 type Work @default.
• W4213092103 citedByCount "3" @default.
• W4213092103 countsByYear W42130921032022 @default.
• W4213092103 countsByYear W42130921032023 @default.
• W4213092103 crossrefType "journal-article" @default.
• W4213092103 hasAuthorship W4213092103A5003681835 @default.
• W4213092103 hasAuthorship W4213092103A5009586319 @default.
• W4213092103 hasAuthorship W4213092103A5012493910 @default.
• W4213092103 hasAuthorship W4213092103A5017132051 @default.
• W4213092103 hasAuthorship W4213092103A5034500754 @default.
• W4213092103 hasAuthorship W4213092103A5057705404 @default.
• W4213092103 hasAuthorship W4213092103A5080149508 @default.
• W4213092103 hasAuthorship W4213092103A5080621630 @default.
• W4213092103 hasAuthorship W4213092103A5088406552 @default.
• W4213092103 hasBestOaLocation W42130921031 @default.
• W4213092103 hasConcept C126322002 @default.
• W4213092103 hasConcept C142724271 @default.
• W4213092103 hasConcept C168563851 @default.
• W4213092103 hasConcept C203092338 @default.
• W4213092103 hasConcept C204787440 @default.
• W4213092103 hasConcept C27081682 @default.
• W4213092103 hasConcept C2777165150 @default.
• W4213092103 hasConcept C2777396551 @default.
• W4213092103 hasConcept C2778168646 @default.
• W4213092103 hasConcept C2779134260 @default.
• W4213092103 hasConcept C2780255968 @default.
• W4213092103 hasConcept C2780479503 @default.
• W4213092103 hasConcept C2911091166 @default.
• W4213092103 hasConcept C501593827 @default.
• W4213092103 hasConcept C523546767 @default.
• W4213092103 hasConcept C535046627 @default.
• W4213092103 hasConcept C54355233 @default.
• W4213092103 hasConcept C71924100 @default.
• W4213092103 hasConcept C86803240 @default.
• W4213092103 hasConcept C89423630 @default.
• W4213092103 hasConcept C90924648 @default.

• next